ANTHONY ALEXANDER: Open Payments
NPI 1831676287 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 84 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $764 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $250 |
| Otsuka America Pharmaceutical, Inc. | 12 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $168 |
| ABBVIE INC. | 12 | $161 |
| Axsome Therapeutics, Inc. | 15 | $157 |
| Teva Pharmaceuticals USA, Inc. | 7 | $127 |
| Vanda Pharmaceuticals Inc. | 3 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $43 |
Products named: COBENFY, CAPLYTA, Auvelity, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, TRINTELLIX, AUSTEDO XR.
Industry payments across MO — which companies pay providers there.
